Community-acquired Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia [Phase 2]
This document reports a Phase II clinical trial evaluating Faropenem for adult community-acquired pneumonia, with the trial status shown as …
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP [Phase 3]
A Phase 3 trial evaluating oral nemonoxacin versus levofloxacin for community-acquired pneumonia has completed. The update does not provide …
-
FDA approval · 2013-06-05FDA Approved: LEVOFLOXACIN — Original Application (Baxter Healthcare Corporation)
FDA approved Baxter Healthcare Corporation's Original Application for levofloxacin (generic), granting clearance for a generic version of th…
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired Pneumonia [Phase 4]
Phase 4 clinical trial comparing monotherapy versus combination therapy for non-severe hospitalized community-acquired pneumonia. The study …
-
CLINICAL_TRIALS trial_result · 2013-03-20Clinical Trial Update: Corticoids in Severe Community-Acquired Pneumonia (CAP) [Phase 4]
Phase 4 trial evaluating corticosteroids for severe community-acquired pneumonia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Pleural Fluid and Serum Procalcitonin in Patients With Parapneumonic Pleural Effusion
A completed clinical trial examining pleural fluid and serum procalcitonin levels in patients with parapneumonic pleural effusion due to com…
-
CLINICAL_TRIALS withdrawal · 2013-02-22Clinical Trial Update: Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia [Phase 3]
A Phase 3 trial comparing tigecycline to ceftriaxone for complicated intra-abdominal infection and community-acquired pneumonia has been wit…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia [Phase 3]
A Phase 3 randomized trial comparing tigecycline with levofloxacin in adults hospitalized with community-acquired pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia [Phase 3]
A Phase 3 trial comparing tigecycline to levofloxacin in hospitalized patients with community-acquired pneumonia has completed.
-
FDA approval · 2012-12-18FDA Approved: AZITHROMYCIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for azithromycin submitted by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Community Acquired Pneumonia [NA]
This clinical trial update reports completion of a study evaluating whether a Bacterial Pneumonia Score can guide antibiotic use in children…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Study Evaluating Management of Patients With Community-Acquired Pneumonia (CAP) or Complicated Skin Infections
AstraZeneca-sponsored trial evaluating management of patients with community-acquired pneumonia and complicated skin and soft tissue infecti…
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Effect of Simvastatin on Pneumonia Prognosis in Elderly Patients [Phase 3]
A Phase 3 clinical trial is investigating whether simvastatin can improve prognosis for elderly patients with community-acquired pneumonia. …
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia [Phase 3]
A Phase 3 trial evaluating ceftobiprole for community-acquired pneumonia has completed. The update does not report trial results in this sou…
-
FDA approval · 2012-07-25FDA Approved: CLARITHROMYCIN — Original Application (Rising Pharma Holdings, Inc.)
FDA approved a generic clarithromycin product under an original ANDA from Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia [Phase 2]
This Phase 2 trial of ONO-5046Na in patients with acute respiratory failure due to community-acquired pneumonia has completed.
-
CLINICAL_TRIALS withdrawal · 2012-06-07Clinical Trial Update: Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia [Phase 3]
A Phase 3 trial evaluating tigecycline versus ceftriaxone for complicated intra-abdominal infections and community-acquired pneumonia has be…
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP) [Phase 3]
A Phase 3 trial evaluating Unasyn-S 12 g/day for community-acquired pneumonia has completed and results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia [Phase 2]
A Phase 2 safety and efficacy study of oral zabofloxacin for community-acquired pneumonia has been terminated, according to the trial update…
-
CLINICAL_TRIALS trial_result · 2012-04-13Clinical Trial Update: A Global Active Surveillance for Community Acquired Pneumonia [NA]
Pfizer-sponsored global active surveillance trial for community-acquired pneumonia has completed.
-
FDA approval · 2012-03-30FDA Approved: LEVOFLOXACIN — Original Application (Chartwell RX, LLC)
FDA approved an original ANDA for Levofloxacin, a generic antibiotic, submitted by Chartwell RX, LLC. The approval enables a generic version…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Community-acquired Pneumonia in Buskerud County in Norway
The clinical trial focusing on community-acquired pneumonia in Buskerud County, Norway has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia
Pfizer-sponsored epidemiologic study in U.S. adults with community-acquired pneumonia examined the distribution of vaccine-type Streptococcu…
-
FDA approval · 2012-02-17FDA Approved: ERTAPENEM — Supplemental Application (ENDO USA, Inc.)
FDA approved a supplemental application for ertapenem (ertapenem sodium) filed by ENDO USA, Inc. This action updates regulatory status for t…
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Telithromycin, Treating Adult Outpatients With Mild to Moderate Community-acquired Pneumonia (CAP) in High Bacterial Resistance Areas [Phase 4]
Phase 4 trial update reporting completion of a study evaluating telithromycin for adults with mild to moderate community-acquired pneumonia …